株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アレルギー診断の世界市場 〜2022年:診断キット、免疫学的測定法 & ELIZA分析装置、ルミノメーター、サービス

Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 321266
出版日 ページ情報 英文 151 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.48円で換算しております。
Back to Top
アレルギー診断の世界市場 〜2022年:診断キット、免疫学的測定法 & ELIZA分析装置、ルミノメーター、サービス Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022
出版日: 2017年08月31日 ページ情報: 英文 151 Pages
概要

アレルギー診断の世界市場は、2017年から2022年にかけて10.5%の複合年間成長率(CAGR)で57億4000万米ドル規模に拡大することが予測されています。市場成長の主な促進要因として、アレルギー疾患患者の増加のほか、環境汚染の拡大、医療費の増大、米国の医療保険制度改革などが挙げられます。製品別に見ると、アッセイキットが今後急速に成長する見通しです。

当レポートでは、アレルギー診断の世界市場に注目し、製品・サービス、アレルゲン (アレルギー誘発物質)、検査方法、エンドユーザー、地域の別にその推移を予測するほか、市場の現況、発展への影響要因、競合環境、有力企業などについて最新の調査・分析情報をまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主要考察

  • アレルギー診断市場の概要
  • アレルギー診断市場:アレルゲン別
  • アレルギー診断市場の地域概要
  • アレルギー診断市場:検査タイプ別

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 推進要因
      • アレルギー疾患の発症率の高さと経済的負担の重さ
      • 環境汚染の拡大
      • 医療費拡大
    • 阻害要因
      • 小規模診な診断所および診療所にとって高額な設備機器
      • アレルギー疾患に対する認知度の低さ
    • 機会
      • アジア太平洋およびその他の地域(RoW)の成長機会
    • 動向
      • オートメーションの導入による診断時間の短縮
      • 検査試薬レンタル契約の登場

第6章 アレルギー診断市場:製品 & サービス別

  • イントロダクション
  • 診断キット
  • 診断装置
  • 免疫測定分析装置
    • ルミノメーター (照度計)
    • ELISA (酵素結合免疫吸着法) 分析装置
    • その他
  • サービス

第7章 アレルギー診断市場:検査法別

  • イントロダクション
  • 生体内 (in vivo) 検査
  • 体外 (in vitro) 検査

第8章 アレルギー診断市場:アレルゲン別

  • イントロダクション
  • 吸入アレルゲン
  • 食品アレルゲン
  • 薬物アレルゲン
  • その他のアレルゲン

第9章 アレルギー診断市場:エンドユーザー別

  • イントロダクション
  • 診断試験所
  • 病院
  • 学術研究機関
  • その他

第10章 アレルギー診断市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州諸国
  • アジア
    • 中国
    • 日本
    • インド
    • その他アジア諸国
  • その他の地域 (ROW)
    • ラテンアメリカ
    • 太平洋・オセアニア
    • 中東・アフリカ

第11章 競合環境

  • イントロダクション
  • 市場シェアの分析
  • リーダーシップマッピング
  • 競合ベンチマーキング

第12章 企業プロファイル

  • イントロダクション
  • THERMO FISHER SCIENTIFIC INC.
  • SIEMENS AG
  • DANAHER CORPORATION
  • OMEGA DIAGNOSTICS GROUP PLC
  • 日立化成
  • BIOMERIEUX SA
  • STALLERGENES GREER
  • HOB BIOTECH GROUP SUZHOU CO., LTD.
  • HYCOR BIOMEDICAL, INC.
  • LINCOLN DIAGNOSTICS, INC.
  • R-BIOPHARM AG

第13章 付録

目次
Product Code: MD 2955

The global allergy diagnostics market is expected to reach USD 5.74 billion by 2022, at a CAGR of 10.5% from 2017 to 2022. The major factors driving this market are the high incidence and large economic burden of allergic diseases, rising environmental pollution levels, increasing healthcare expenditure, and growing access to medical insurance in the US. On the other hand, the growth of this market is hindered to some extent due to the limited awareness about allergy diagnosis in some developing countries.

Assay kits to register the highest CAGR during the forecast period

The allergy diagnostics market is classified on the basis of product & service into assay kits, instruments, and services. The assay kits segment is expected to grow at the highest rate during the forecast period. The widespread availability and large consumption of assay kits in allergy testing are expected to drive the growth of this segment in the coming years.

Diagnostic laboratories to dominate the allergy diagnostics market during the forecast period

The allergy diagnosis market is segmented based on end users into diagnostic laboratories, hospital-based laboratories, academic & research institutes, and other end users. In 2017, the diagnostic laboratories segment is expected to command the largest share and is estimated to grow at the fastest rate as compared to other segments. The market is mainly driven by the increasing incidence of allergic disorders in emerging countries.

Asia is estimated to be the fastest growing regional segment in the market during the forecast period

Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The Asian region is estimated to grow at the fastest rate which can be attributed to the improving life sciences research infrastructure in emerging economies and rising investments by governments to promote research activities.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 70% and Tier 2 - 30%
  • By Designation - C-level - 62%, Director Level - 21%, Others - 17%
  • By Region - North America - 20%, Europe - 30%, Asia - 50%

The key players in the market are: Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMerieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abello A/S (Denmark), Angsana Molecular & Diagnostics Laboratory Pte Ltd. (Singapore), Allergy Therapeutics (UK), Astra Biotech GmbH (Germany), HAL Allergy Group (Netherlands), Theradiag (France), and Demeditec Diagnostics GmbH (Germany).

Study Coverage:

The report analyses the allergy diagnostics market by product and service, test, allergen, end user, and region. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the type, products, test, end users, and regions.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the allergy diagnostics market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the allergy diagnostics market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the allergy diagnostics market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various allergy diagnostic products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the allergy diagnostics market

TABLE OF CONTENTS

1 INTRODUCTION 14

  • 1.1 OBJECTIVES OF THE STUDY 14
  • 1.2 MARKET DEFINITION 14
    • 1.2.1 MARKETS COVERED 15
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY 15
  • 1.3 CURRENCY 16
  • 1.4 LIMITATIONS 16
  • 1.5 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17

  • 2.1 RESEARCH DATA 17
    • 2.1.1 SECONDARY DATA 18
      • 2.1.1.1 Secondary sources 18
    • 2.1.2 PRIMARY DATA 19
      • 2.1.2.1 Primary sources 19
  • 2.2 MARKET SIZE ESTIMATION 20
    • 2.2.1 BOTTOM-UP APPROACH 20
    • 2.2.2 TOP-DOWN APPROACH 21
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 22
  • 2.4 ASSUMPTIONS FOR THE STUDY 23

3 EXECUTIVE SUMMARY 24

4 PREMIUM INSIGHTS 30

  • 4.1 ALLERGY DIAGNOSTICS: MARKET OVERVIEW 30
  • 4.2 ALLERGY DIAGNOSTICS MARKET, BY ALLERGENS (2017) 31
  • 4.3 GEOGRAPHIC SNAPSHOT OF THE ALLERGY DIAGNOSTICS MARKET 32
  • 4.4 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2017 VS. 2022 32

5 MARKET OVERVIEW 33

  • 5.1 INTRODUCTION 34
  • 5.2 MARKET DYNAMICS 34
    • 5.2.1 DRIVERS 35
      • 5.2.1.1 High incidence and large economic burden of allergic diseases 35
      • 5.2.1.2 Rising environmental pollution levels 35
      • 5.2.1.3 Increasing healthcare expenditure 36
      • 5.2.1.4 Increasing access for allergy diagnosis medical insurance in the US 37

    • 5.2.2 RESTRAINTS 37
      • 5.2.2.1 Issues related to the affordability of allergy diagnostics instruments among small laboratories and physician clinics 37
      • 5.2.2.2 Low awareness of allergic diseases 37
    • 5.2.3 OPPORTUNITIES 38
      • 5.2.3.1 Emerging economies across Asia and RoW 38
    • 5.2.4 TRENDS 38
      • 5.2.4.1 Growing adoption of automation for quicker turnaround times 38
      • 5.2.4.2 Growth in the number of reagent rental agreements 39

6 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 40

  • 6.1 INTRODUCTION 41
  • 6.2 ASSAY KITS 42
  • 6.3 INSTRUMENTS 43
    • 6.3.1 IMMUNOASSAY ANALYZERS 44
    • 6.3.2 LUMINOMETERS 45
    • 6.3.3 ELISA ANALYZERS 46
    • 6.3.4 OTHER INSTRUMENTS 47
  • 6.4 SERVICES 48

7 ALLERGY DIAGNOSTICS MARKET, BY TEST 49

  • 7.1 INTRODUCTION 50
  • 7.2 IN VIVO TESTS 51
  • 7.3 IN VITRO TESTS 52

8 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN 53

  • 8.1 INTRODUCTION 54
  • 8.2 INHALED ALLERGENS 55
  • 8.3 FOOD ALLERGENS 56
  • 8.4 DRUG ALLERGENS 57
  • 8.5 OTHER ALLERGENS 58

9 ALLERGY DIAGNOSTICS MARKET, BY END USER 59

  • 9.1 INTRODUCTION 60
  • 9.2 DIAGNOSTIC LABORATORIES 61
  • 9.3 HOSPITAL-BASED LABORATORIES 62
  • 9.4 ACADEMIC RESEARCH INSTITUTES 63
  • 9.5 OTHER END USERS 64

10 ALLERGY DIAGNOSTICS MARKET, BY REGION 65

  • 10.1 INTRODUCTION 66
  • 10.2 NORTH AMERICA 67
    • 10.2.1 US 71
    • 10.2.2 CANADA 73
  • 10.3 EUROPE 75
    • 10.3.1 GERMANY 77
    • 10.3.2 UK 79
    • 10.3.3 FRANCE 81
    • 10.3.4 ITALY 83
    • 10.3.5 SPAIN 85
    • 10.3.6 REST OF EUROPE (ROE) 87
  • 10.4 ASIA 89
    • 10.4.1 CHINA 93
    • 10.4.2 JAPAN 95
    • 10.4.3 INDIA 97
    • 10.4.4 REST OF ASIA (ROA) 99
  • 10.5 REST OF THE WORLD 101
    • 10.5.1 LATIN AMERICA 103
    • 10.5.2 PACIFIC AND OCEANIA 105
    • 10.5.3 MIDDLE EAST AND AFRICA 107

11 COMPETITIVE LANDSCAPE 110

  • 11.1 INTRODUCTION 110
  • 11.2 MARKET SHARE ANALYSIS 110
  • 11.3 COMPETITIVE LEADERSHIP MAPPING 111
    • 11.3.1 VISIONARY LEADERS 111
    • 11.3.2 INNOVATORS 111
    • 11.3.3 DYNAMIC DIFFERENTIATORS 112
    • 11.3.4 EMERGING COMPANIES 112
  • 11.4 COMPETITIVE BENCHMARKING 113
    • 11.4.1 STRENGTH OF PRODUCT PORTFOLIO (25 PLAYERS) 113
    • 11.4.2 BUSINESS STRATEGY EXCELLENCE (25 PLAYERS) 114

12 COMPANY PROFILES 115

(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*

  • 12.1 THERMO FISHER SCIENTIFIC INC. 115
  • 12.2 SIEMENS AG 118
  • 12.3 DANAHER CORPORATION 121
  • 12.4 OMEGA DIAGNOSTICS GROUP PLC 124
  • 12.5 HITACHI CHEMICAL CO., LTD. 126
  • 12.6 BIOMERIEUX SA 128
  • 12.7 STALLERGENES GREER 131
  • 12.8 HOB BIOTECH GROUP SUZHOU CO., LTD. 133
  • 12.9 HYCOR BIOMEDICAL, INC. 135
  • 12.10 LINCOLN DIAGNOSTICS, INC. 137
  • 12.11 R-BIOPHARM AG 139

Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX 141

  • 13.1 INSIGHTS FROM INDUSTRY EXPERTS 141
  • 13.2 DISCUSSION GUIDE 142
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 144
  • 13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 146
  • 13.5 AVAILABLE CUSTOMIZATIONS 148
  • 13.6 RELATED REPORTS 148
  • 13.7 AUTHOR DETAILS 149

LIST OF TABLES

  • TABLE 1: ALLERGY DIAGNOSTICS MARKET SUMMARY 24
  • TABLE 2: HEALTHCARE EXPENDITURE, BY COUNTRY, 2005-2014 (USD BILLION) 36
  • TABLE 3: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 41
  • TABLE 4: ALLERGY DIAGNOSTICS ASSAY KITS MARKET, BY REGION, 2015-2022 (USD MILLION) 42
  • TABLE 5: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION) 43
  • TABLE 6: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION) 44
  • TABLE 7: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2015-2022 (USD MILLION) 45
  • TABLE 8: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET FOR LUMINOMETERS, BY REGION, 2015-2022 (USD MILLION) 45
  • TABLE 9: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET FOR ELISA ANALYZERS, BY REGION, 2015-2022 (USD MILLION) 46
  • TABLE 10: OTHER ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION) 47
  • TABLE 11: ALLERGY DIAGNOSTICS SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION) 48
  • TABLE 12: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 50
  • TABLE 13: IN VIVO ALLERGY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION) 51
  • TABLE 14: IN VITRO ALLERGY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION) 52
  • TABLE 15: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 54
  • TABLE 16: INHALED ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION) 55
  • TABLE 17: FOOD ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION) 56
  • TABLE 18: DRUG ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION) 57
  • TABLE 19: OTHER ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION) 58
  • TABLE 20: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 60
  • TABLE 21: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2015-2022 (USD MILLION) 61
  • TABLE 22: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2015-2022 (USD MILLION) 62
  • TABLE 23: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION) 63
  • TABLE 24: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION) 64
  • TABLE 25: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION) 66
  • TABLE 26: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION) 69
  • TABLE 27: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 69
  • TABLE 28: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 69
  • TABLE 29: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 70
  • TABLE 30: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 70
  • TABLE 31: US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 71
  • TABLE 32: US: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 71
  • TABLE 33: US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 72
  • TABLE 34: US: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 72
  • TABLE 35: CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 73
  • TABLE 36: CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 73
  • TABLE 37: CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 74
  • TABLE 38: CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 74
  • TABLE 39: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION) 75
  • TABLE 40: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 76
  • TABLE 41: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 76
  • TABLE 42: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 76
  • TABLE 43: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 77
  • TABLE 44: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 78
  • TABLE 45: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 78
  • TABLE 46: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 78
  • TABLE 47: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 79
  • TABLE 48: UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 80
  • TABLE 49: UK: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 80
  • TABLE 50: UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 80
  • TABLE 51: UK: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 81
  • TABLE 52: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 82
  • TABLE 53: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 82
  • TABLE 54: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 82
  • TABLE 55: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 83
  • TABLE 56: ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 84
  • TABLE 57: ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 84
  • TABLE 58: ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 84
  • TABLE 59: ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 85
  • TABLE 60: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 86
  • TABLE 61: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 86
  • TABLE 62: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 86
  • TABLE 63: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 87
  • TABLE 64: ROE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 87
  • TABLE 65: ROE: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 88
  • TABLE 66: ROE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 88
  • TABLE 67: ROE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 88
  • TABLE 68: ASIA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION) 91
  • TABLE 69: ASIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 91
  • TABLE 70: ASIA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 91
  • TABLE 71: ASIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 92
  • TABLE 72: ASIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 92
  • TABLE 73: CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 93
  • TABLE 74: CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 94
  • TABLE 75: CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 94
  • TABLE 76: CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 94
  • TABLE 77: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 95
  • TABLE 78: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 96
  • TABLE 79: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 96
  • TABLE 80: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 96
  • TABLE 81: INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 97
  • TABLE 82: INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 98
  • TABLE 83: INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 98
  • TABLE 84: INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 98
  • TABLE 85: ROA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 99
  • TABLE 86: ROA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 99
  • TABLE 87: ROA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 100
  • TABLE 88: ROA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 100
  • TABLE 89: ROW: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION) 101
  • TABLE 90: ROW: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 101
  • TABLE 91: ROW: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 102
  • TABLE 92: ROW: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 102
  • TABLE 93: ROW: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 102
  • TABLE 94: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 103
  • TABLE 95: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 103
  • TABLE 96: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 104
  • TABLE 97: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 104
  • TABLE 98: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 105
  • TABLE 99: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 106
  • TABLE 100: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 106
  • TABLE 101: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 107
  • TABLE 102: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION) 108
  • TABLE 103: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION) 108
  • TABLE 104: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION) 109
  • TABLE 105: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION) 109

LIST OF FIGURES

  • FIGURE 1: GLOBAL ALLERGY DIAGNOSTICS MARKET 15
  • FIGURE 2: RESEARCH DESIGN 17
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 19
  • FIGURE 4: ALLERGY DIAGNOSTICS MARKET: BOTTOM-UP APPROACH 20
  • FIGURE 5: ALLERGY DIAGNOSTICS MARKET: TOP-DOWN APPROACH 21
  • FIGURE 6: DATA TRIANGULATION 22
  • FIGURE 7: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017 VS. 2022 (USD BILLION) 25
  • FIGURE 8: ALLERGY DIAGNOSTICS MARKET, BY ALLERGENS, 2017 VS. 2022 (USD BILLION) 26
  • FIGURE 9: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2017 VS. 2022 (USD BILLION) 27
  • FIGURE 10: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2017 VS. 2022 (USD BILLION) 28
  • FIGURE 11: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2017 VS. 2022 (USD BILLION) 29
  • FIGURE 12: HIGH INCIDENCE AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES IS EXPECTED TO DRIVE THE MARKET 30
  • FIGURE 13: INHALED ALLERGENS SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2017 31
  • FIGURE 14: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 32
  • FIGURE 15: IN VIVO TESTS TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET DURING 2017 TO 2022 32
  • FIGURE 16: ALLERGY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS 34
  • FIGURE 17: ASSAY KITS TO FORM THE LARGEST PRODUCT SEGMENT IN 2017 41
  • FIGURE 18: IN VIVO TESTS SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET DURING 2017-2022 50
  • FIGURE 19: INHALED ALLERGENS SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2017 54
  • FIGURE 20: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2017 VS. 2022 (USD MILLION) 60
  • FIGURE 21: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2017 66
  • FIGURE 22: NORTH AMERICA: ALLERGY DIAGNOSIS MARKET SNAPSHOT 68
  • FIGURE 23: ASIA: ALLERGY DIAGNOSTICS MARKET SNAPSHOT 90
  • FIGURE 24: GLOBAL ALLERGY DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 110
  • FIGURE 25: ALLERGY DIAGNOSTICS MARKET (GLOBAL): COMPETITIVE LEADERSHIP MAPPING, 2017 112
  • FIGURE 26: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016) 115
  • FIGURE 27: SIEMENS AG: COMPANY SNAPSHOT (2016) 118
  • FIGURE 28: DANAHER CORPORATION: COMPANY SNAPSHOT (2016) 121
  • FIGURE 29: OMEGA DIAGNOSTICS GROUP PLC: COMPANY SNAPSHOT (2016) 124
  • FIGURE 30: HITACHI CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2016) 126
  • FIGURE 31: BIOMERIEUX SA: COMPANY SNAPSHOT (2016) 128
  • FIGURE 32: STALLERGENES GREER: COMPANY SNAPSHOT (2016) 131
Back to Top